<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21880596</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>22</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth.</ArticleTitle><Pagination><StartPage>9633</StartPage><EndPage>9648</EndPage><MedlinePgn>9633-48</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkr682</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is associated with severe neurological disorders in children, and has been implicated as the infectious agent in several large-scale outbreaks with mortalities. Upon infection, the viral RNA is translated in a cap-independent manner to yield a large polyprotein precursor. This mechanism relies on the presence of an internal ribosome entry site (IRES) element within the 5'-untranslated region. Virus-host interactions in EV71-infected cells are crucial in assisting this process. We identified a novel positive IRES trans-acting factor, far upstream element binding protein 1 (FBP1). Using binding assays, we mapped the RNA determinants within the EV71 IRES responsible for FBP1 binding and mapped the protein domains involved in this interaction. We also demonstrated that during EV71 infection, the nuclear protein FBP1 is enriched in cytoplasm where viral replication occurs. Moreover, we showed that FBP1 acts as a positive regulator of EV71 replication by competing with negative ITAF for EV71 IRES binding. These new findings may provide a route to new anti-viral therapy.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2011. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Peng-Nien</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jing-Yi</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Locker</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Yu-An</ForeName><Initials>YA</Initials></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Chuan-Tien</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jhao-Yin</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hsing-I</ForeName><Initials>HI</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492258">FUBP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105789">KHSRP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="Y">5' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001667" MajorTopicYN="N">Binding, Competitive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21880596</ArticleId><ArticleId IdType="pmc">PMC3239202</ArticleId><ArticleId IdType="doi">10.1093/nar/gkr682</ArticleId><ArticleId IdType="pii">gkr682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C, Shih SR, Liu CC, Wu MH. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 2002;34(Suppl. 2):S52&#x2013;S57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr. Infect. Dis. J. 1988;7:484&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J, Roth B, Metzger C, Pfitzner A, Enders G. Molecular characterization of an enterovirus 71 causing neurological disease in Germany. J. Neurovirol. 2003;9:126&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J. Virol. 2001;75:7732&#x2013;7738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuffenecker I, Mirand A, Antona D, Henquell C, Chomel JJ, Archimbaud C, Billaud G, Peigue-Lafeuille H, Lina B, Bailly JL. Epidemiology of human enterovirus 71 infections in France, 2000&#x2013;2009. J. Clin. Virol. 2010;50:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035387</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lam SK. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999;61:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, Jr, Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2013;United States, 1977-1991. J. Infect. Dis. 1994;169:905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 2009;47:2351&#x2013;2352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SR, Sarnow P. Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology. 2003;315:259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton DJ, O'Donnell BJ, Flanegan JB. 5&#x2032; cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J. 2001;20:1439&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145522</ArticleId><ArticleId IdType="pubmed">11250909</ArticleId></ArticleIdList></Reference><Reference><Citation>de Breyne S, Yu Y, Unbehaun A, Pestova TV, Hellen CU. Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc. Natl Acad. Sci. USA. 2009;106:9197&#x2013;9202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695064</ArticleId><ArticleId IdType="pubmed">19470487</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyn LB, Towner JS, Semler BL, Ehrenfeld E. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 1997;71:6243&#x2013;6246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191892</ArticleId><ArticleId IdType="pubmed">9223526</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussadia O, Niepmann M, Creancier L, Prats AC, Dautry F, Jacquemin-Sablon H. Unr is required in vivo for efficient initiation of translation from the internal ribosome entry sites of both rhinovirus and poliovirus. J. Virol. 2003;77:3353&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149491</ArticleId><ArticleId IdType="pubmed">12610110</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M, Svitkin Y, Sonenberg N. La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol. Cell. Biol. 2004;24:6861&#x2013;6870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC444852</ArticleId><ArticleId IdType="pubmed">15254251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5&#x2032; untranslated region and participates in virus replication. J. Gen. Virol. 2008;89:2540&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">18796723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 2000;14:2028&#x2013;2045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316860</ArticleId><ArticleId IdType="pubmed">10950867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafasla P, Morgner N, Poyry TA, Curry S, Robinson CV, Jackson RJ. Polypyrimidine tract binding protein stabilizes the encephalomyocarditis virus IRES structure via binding multiple sites in a unique orientation. Mol. Cell. 2009;34:556&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pubmed">19524536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafasla P, Morgner N, Robinson CV, Jackson RJ. Polypyrimidine tract-binding protein stimulates the poliovirus IRES by modulating eIF4G binding. EMBO J. 2010;29:3710&#x2013;3722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2982756</ArticleId><ArticleId IdType="pubmed">20859255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009;37:47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615614</ArticleId><ArticleId IdType="pubmed">19010963</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M, Levens D. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 1994;8:465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">8125259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, Zhao K, Levens D. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J. 2006;25:2119&#x2013;2130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1462968</ArticleId><ArticleId IdType="pubmed">16628215</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 2000;19:1034&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305642</ArticleId><ArticleId IdType="pubmed">10698944</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Weber A, Levens D. Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor. Nucleic Acids Res. 2000;28:4558&#x2013;4565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113884</ArticleId><ArticleId IdType="pubmed">11071946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Harris D, Pandey VN. The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus. J. Virol. 2008;82:5761&#x2013;5773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395142</ArticleId><ArticleId IdType="pubmed">18400844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien HL, Liao CL, Lin YL. FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication. J. Virol. 2011;85:4698&#x2013;4706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126168</ArticleId><ArticleId IdType="pubmed">21367899</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Lidsky PV, Mikitas OV, Egger D, Lukyanov KA, Bienz K, Agol VI. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 2004;78:10166&#x2013;10177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514989</ArticleId><ArticleId IdType="pubmed">15331749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol S, Sartor BR, Singer MV. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin. Exp. Immunol. 2003;131:53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1808611</ArticleId><ArticleId IdType="pubmed">12519386</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5:e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Akoulitchev S, Weber A, Ge H, Chuikov S, Libutti D, Wang XW, Conaway JW, Harris CC, Conaway RC, et al. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell. 2001;104:353&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239393</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AE, Reid SM, Knowles NJ, Hutchings GH, Wilsden G, Brocchi E, Paton D, King DP. Sequence analysis of the 5&#x2032; untranslated region of swine vesicular disease virus reveals block deletions between the end of the internal ribosomal entry site and the initiation codon. J. Gen. Virol. 2005;86:2753&#x2013;2761.</Citation><ArticleIdList><ArticleId IdType="pubmed">16186229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulygin K, Baouz-Drahy S, Graifer D, Favre A, Karpova G. Sites of 18S rRNA contacting mRNA 3&#x2032; and 5&#x2032; of the P site codon in human ribosome: a cross-linking study with mRNAs carrying 4-thiouridines at specific positions. Biochim. Biophys. Acta. 2009;1789:167&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">19118656</ArticleId></ArticleIdList></Reference><Reference><Citation>Graifer D, Molotkov M, Styazhkina V, Demeshkina N, Bulygin K, Eremina A, Ivanov A, Laletina E, Ven'yaminova A, Karpova G. Variable and conserved elements of human ribosomes surrounding the mRNA at the decoding and upstream sites. Nucleic Acids Res. 2004;32:3282&#x2013;3293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC443533</ArticleId><ArticleId IdType="pubmed">15208366</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheper GC, Voorma HO, Thomas AA. Basepairing with 18S ribosomal RNA in internal initiation of translation. FEBS Lett. 1994;352:271&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">7925985</ArticleId></ArticleIdList></Reference><Reference><Citation>Schluenzen F, Tocilj A, Zarivach R, Harms J, Gluehmann M, Janell D, Bashan A, Bartels H, Agmon I, Franceschi F, et al. Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. Cell. 2000;102:615&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">11007480</ArticleId></ArticleIdList></Reference><Reference><Citation>Niepmann M, Petersen A, Meyer K, Beck E. Functional involvement of polypyrimidine tract-binding protein in translation initiation complexes with the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 1997;71:8330&#x2013;8339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192292</ArticleId><ArticleId IdType="pubmed">9343186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard KM, Walter BL, Semler BL. Multimerization of poly(rC) binding protein 2 is required for translation initiation mediated by a viral IRES. RNA. 2004;10:1266&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370616</ArticleId><ArticleId IdType="pubmed">15247434</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig AW, Svitkin YV, Lee HS, Belsham GJ, Sonenberg N. The La autoantigen contains a dimerization domain that is essential for enhancing translation. Mol. Cell. Biol. 1997;17:163&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231740</ArticleId><ArticleId IdType="pubmed">8972196</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Tzima E, Ochs K, Bassili G, Trusheim H, Linder M, Preissner KT, Niepmann M. Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation. RNA. 2005;11:1809&#x2013;1824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370870</ArticleId><ArticleId IdType="pubmed">16314455</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowska J, Hansen SJ, Park N, Jamka K, Sarnow P, Gustin KE. Stable formation of compositionally unique stress granules in virus-infected cells. J. Virol. 2010;84:3654&#x2013;3665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838110</ArticleId><ArticleId IdType="pubmed">20106928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustin KE, Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 2001;20:240&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140206</ArticleId><ArticleId IdType="pubmed">11226174</ArticleId></ArticleIdList></Reference><Reference><Citation>Park N, Katikaneni P, Skern T, Gustin KE. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008;82:1647&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2258732</ArticleId><ArticleId IdType="pubmed">18045934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan W, LaCelle M, Rhoads RE. Functional characterization of the internal ribosome entry site of eIF4G mRNA. J. Biol. Chem. 1998;273:5006&#x2013;5012.</Citation><ArticleIdList><ArticleId IdType="pubmed">9478948</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B, Zhang JT. Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story. Mol. Cell. Biol. 2002;22:7372&#x2013;7384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135655</ArticleId><ArticleId IdType="pubmed">12370285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>